New Study Identifies Challenges for COVID-19 Vaccine Adoption

▴ New Study Identifies Challenges for COVID-19 Vaccine Adoption
Advisory firm Avenue Group® conducted a series of one-on-one, in-depth phone interviews with doctors, nurses, and members of the general public to better understand what needs to happen in order for Americans to feel comfortable choosing to take a COVID-19 vaccine.

Advisory firm Avenue Group® conducted a series of one-on-one, in-depth phone interviews with doctors, nurses, and members of the general public to better understand what needs to happen in order for Americans to feel comfortable choosing to take a COVID-19 vaccine.

The World Health Organization estimates that 65 to 75 percent of the population well over 200 million Americans need to have antibodies either by means of a vaccine or through recovery from the virus to reach herd immunity. Last month, Dr. Anthony Fauci said, "We know what the efficacy of the vaccines is, but its effectiveness will depend on how many people take the vaccine."

Avenue Group's research identified several areas that need to be addressed to increase the vaccination adoption rate. Avenue Group Founder Jeremy Greenberg said, "Only half of the participants told us that they are likely to take a COVID-19 vaccine. Vaccine safety and side effects are viewed as the most important factors driving the vaccination decision. Two-thirds of those not likely to take the vaccine doubt the safety of it. These are concerning issues that need to be addressed by policy leaders and health experts."

Several concerning themes emerged from Avenue Group's interviews: women are more often the gatekeepers for households and are less likely to take a COVID-19 vaccine than men, over one-third of doctors and nurses are not yet supportive of taking a vaccine, and some do not consider their doctor's recommendation important and are leery of new vaccines.

There were encouraging themes as well. President-elect Joe Biden's victory had a net positive impact on vaccination adoption. Half of Biden voters said that Biden's forthcoming oversight of distribution makes them more likely to take it, while Trump voters said that their vaccine decision is unaffected by who is president. Older and high-risk participants were more likely to take the vaccine. A 74-year-old retired participant from Port St. Lucie, Florida, said, "It makes sense for me. I'm older and I have a low immune system."

About the Study:

Avenue Group conducted confidential one-on-one interviews over the phone between November 13-23, 2020, during a surge in coronavirus cases across the U.S., and, after President-elect Joe Biden had been declared the winner of the presidential election. The average interview length was 30 minutes. The 40 participants in the study included 17 individuals from the medical community (11 doctors, six nurses) and 23 members of the general public.

The findings from this small study should be considered directional as this was not a large population study, and we prioritized deeper, live interactions over sample size. Participants constituted a diverse representation of American society, across gender, race, income, geography, employment status, level of education, political affiliation, and other demographic factors.

About Avenue Group: Avenue Group® advises private equity firms, Fortune 500s, mid-market companies, and non-profits. The company combines data with a firsthand narrative to drive smarter decisions with a primary research-first approach. Avenue Group sources conduct and analyze in-depth interviews and surveys to develop meaningful actionable insights for clients. The firm generates real-time market feedback to move beyond existing data and industry stereotypes.

Tags : #NewYork #America #AvenueGroup #WHO #Covid19 #Covid19VAccine #DrAnthonyFauci #FightAgainstVirus #Vaccination

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Sanmarg Auto++: Revolutionizing Mobility at Kolkata’s Biggest Auto FairMarch 22, 2025
39th Prof. M. Viswanathan Oration Highlights Strategies to Prevent Diabetic Foot AmputationsMarch 22, 2025
Catapulting funding crisis into opportunity by getting on track to end TB and tobacco useMarch 22, 2025
University of Leeds Opens Applications for MSc in Sustainable Agriculture & Food Production for Indian StudentsMarch 21, 2025
Crompton Reimagines Lighting with Launch of INFINIA - 20% Extra Brightness & SlimO - Ultra-Sleek Appeal!March 21, 2025
March 21, 2025
World Down Syndrome Day: Why India is Still Failing Its Special ChildrenMarch 21, 2025
The Digital Delusion: How Social Media Is Rewiring Your RealityMarch 21, 2025
Can Giving Blood Lower Your Risk of Heart Disease and Diabetes? Find OutMarch 21, 2025
Embracing Extra Chromosomes: Individuals with Down Syndrome face health challenges, stigma, and limited care, but early intervention and inclusion can transform their livesMarch 20, 2025
Why Doctors May Soon Prescribe Walks in the Park Instead of PillsMarch 20, 2025
Today some of the LIC agents met the Hon’ble Leader of Opposition and raised certain issues.March 20, 2025
Sarvodaya Healthcare, in partnership with Oncidium Foundation, becomes India’s first to offer Nuclear Therapy for cancer patientsMarch 20, 2025
Sarvodaya Healthcare, in partnership with Oncidium Foundation, becomes India’s first to offer Nuclear Therapy for cancer patientsMarch 20, 2025
Think Alcohol Is Bad for You? New Research Might Prove You WrongMarch 20, 2025
Lilly Launches Mounjaro® (tirzepatide), offering a new option for the treatment of obesity and type 2 diabetesMarch 20, 2025
How can we leave those behind who are at higher TB risk?March 20, 2025
The Global Tuberculosis Fight: Why Prevention Holds Key to EradicationMarch 20, 2025
Chew Your Way to a Sharper Mind: The Surprising Brain Hack No One Told You AboutMarch 20, 2025
Danger of substandard and falsified medical products is real and growingMarch 19, 2025